NIDB 3101
Alternative Names: NI-3101; NIDB-3101Latest Information Update: 12 Jan 2021
At a glance
- Originator Discoveric Bio; Light Chain Bioscience
- Class Antibodies; Antidementias
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Alzheimer's disease